how big is the glp 1 market GLP-1 Drug Market: rapid growth of the diabetes and obesity drugs GLP-1 Nutritional Support Market Size

Worth mentioning is that the degree of reduced food intake between efocipegtrutide and liraglutide (A GLP1R agonist) treated mice did not differ [35] , demonstrating that the enhanced weight decrease was occurring through enhanced energy expenditure

doi: 10.3390/nu9080882

Conclusion The study found that GLP-1RA therapy is effective not only in managing blood glucose levels in individuals with type 2 diabetes but also in reducing body weight in obese individuals and changing unhealthy eating tendencies, such as the tendency to eat in response to external food cues (external eating)

Trends Endocrinol Metabol

In ELIXA, the beneficial role of lixisenatide on UACR progression was evident only following statistical adjustments for predisposing factors in patients with baseline MA [12]

The catch is you have to do it regularly